Journal
/
Imunologia e Infecção
/
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
JoVE Journal
Imunologia e Infecção
This content is Free Access.
JoVE Journal Imunologia e Infecção
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

DOI:
10.3791/50070-v

•

09:29 min

•

February 01, 2013

•

, , , , , , , ,
1Division of Pediatrics,U.T. MD Anderson Cancer Center, 2Department of Stem Cell Transplantation and Cellular Therapy,U.T. MD Anderson Cancer Center

Capítulos

  • 00:05Título
  • 02:09Isolation of Mononuclear Cells from PB and UCB
  • 03:04Preparation of T Cells for Electroporation
  • 04:03Electroporation of MNC
  • 05:59FACS Analysis of CAR Expression (Day 1)
  • 06:32Preparation of aAPC (Clone #4) on Day 1
  • 07:01aAPC-mediated Stimulation of CAR+ T Cells (Day 1)
  • 07:33Results: SB System Coupled with Co-culture on aAPC Generates CD19-specific CAR+ T Cells
  • 08:44Conclusion

Summary

Tadução automática

Tadução automática

T cells expressing a CD19-specific chimeric antigen receptor (CAR) are infused as investigational treatment of B-cell malignancies in our first-in-human gene therapy trials. We describe genetic modification of T cells using the Sleeping Beauty (SB) system to introduce CD19-specific CAR and selective propagation on designer CD19+ artificial antigen presenting cells.

Tags

Keywords: Sleeping BeautyArtificial Antigen Presenting CellsGenetic ModificationT CellsPeripheral BloodUmbilical Cord BloodCAR T CellsCD19Gene TherapyImmunotherapyTumor-associated AntigensClinical Application

Article

Embed

ADICIONAR À PLAYLIST

Usage Statistics

Vídeos Relacionados

check_url/pt/50070?article_type=v

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
check_url/pt/50070?article_type=v

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
check_url/pt/50070?article_type=v

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
check_url/pt/50070?article_type=v

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells
check_url/pt/50070?article_type=v

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
check_url/pt/50070?article_type=v

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
check_url/pt/50070?article_type=v

Generation of Human Alloantigen-specific T Cells from Peripheral Blood
check_url/pt/50070?article_type=v

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
check_url/pt/50070?article_type=v

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
check_url/pt/50070?article_type=v

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Read Article